UICC & ISOPP Joint Statement: Ensuring quality and equity in cancer treatment
📢 New Joint Statement from International Society of Oncology Pharmacy Practitioners (ISOPP) and Union for International Cancer Control (UICC)
Substandard and falsified (SF) cancer medicines are jeopardising treatment outcomes and patient safety in low- and middle-income countries. A recent study published in The Lancet Global Health revealed that 1 in 6 chemotherapy medicines sampled in sub-Saharan Africa failed to meet international standards.
In response, ISOPP and UICC have issued a joint statement calling for urgent global action to strengthen medicine quality across the supply chain—from regulation and procurement to delivery and use.
📌 Read the full statement and join us in advocating for equitable, high-quality cancer care:
🔗 Statement: https://lnkd.in/eKbQK_vc and https://lnkd.in/e23ppHDG
🔗 Publication: https://lnkd.in/eE8fXkSx
